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1 Introduction
1.1 Innate and adaptive immune system
The purpose of this study was to characterize the viability and the differentiation
of human peripheral monocytes cultured in suspension. To identify our novel
cell type we have tested its capacity to perform some of the classical functions
of monocytes, macrophages and dendritic cells (DCs). The diverse functions of
monocytes and its more differentiated forms macrophages and DCs are integral
to and interconnect the innate and adaptive immune systems. Below is a short
review of the innate and adaptive immune system and how the effector functions
of these cells contribute to resolve various immunological challenges.
1.1.1 Innate immune system
The immune system is based on the very ancient innate immune system that
vertebrates share with invertebrates and plants. It relies on epithelial barriers,
microbicidal environments and cell surface receptors for conserved pathogen-
associated molecular patterns (PAMPs) (Gordon, 2002). This germ-line encoded
pattern recognition receptors (PRRs) allow a perfect self/non-self discrimina-
tion, selected over evolutionary time (Taylor et al., 2005). The cells of the innate
immune system survey the organism for pathologic antigen and have the power
to decide, relying on their PRRs, whether or not to react to a certain stimulus
(Janeway and Medzhitov, 2002). The inflammatory response of macrophages,
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DCs, polymorphonuclear leukocytes, natural killer cells, and mast cells resolve
the attack of pathogenic microbes through a wide variety of methods. But, as
microbes have developed mechanisms to evade the innate immune system, the
means of the innate immune response are not always sufficient to entirely clear
the situation.
1.1.2 Adaptive immune system
Only vertebrates have developed an adaptive immune system in addition to the
innate system. It consists of two lymphocytes species, the T and the B cells. The
diversity of their receptors, T cell receptor (TCR) and antibodies, respectively,
is the result of random receptor gene rearrangement and somatic hypermutation
leading to myriad possible clonal T and B cells. As the random nature of this
receptor generation cannot exclude self-reacting properties, the T cells undergo
positive and negative selection in the thymus during ontogenesis.
1.1.3 Activation of the adaptive immune system
The adaptive immune system can only be activated by the innate immune sys-
tem. The TCR and the major histocompatibility complex (MHC) molecules
link the two apparently distinct systems. T cells cannot react to any native
antigen; rather, the antigen has to be presented by a surface MHC molecule
(Unanue, 2002). There are two classes of MHC molecules. Class I molecules are
expressed on all nucleated cells and present fragments of peptides circulating in
the cell cytoplasm and interact with cluster of differentiation (CD)8+ T cells.
Class II molecules are restricted to professional antigen presenting cells (APCs),
including macrophages, DCs and B cells. These class II molecules present pep-
tide fragments of phagocytized particles and interact with CD4+ T cells. To
activate the adaptive immune system, a peptide-bound MHC molecule must be
2
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identified by a specific TCR. For T cell proliferation and to avoid T cell anergy,
the co-stimulatory molecules CD80 and/or CD86 must be expressed on the very
same cell as the MHC-peptide complex. In APCs this co-stimulatory molecules
are up-regulated upon stimulation following PRR engagement (Taylor et al.,
2005). So, the stimulation of the innate system precedes the activation of the
adaptive immune system.
1.1.4 Effector functions of the adaptive immune system
The effector functions of the adaptive immune system are, with exception of
the cytotoxic CD8+ killer cells, mediated by the innate immune system. The
link therefore are the CD4+ cells, also called T helper cells, which are divided
into two major groups, the type 1 (TH1) and type 2 (TH2) cells. A TH1 cell
can maximize the killing efficacy of a macrophage presenting the same MHC-
peptide complex with which the T cell has been activated. They also induce
the proliferation of CD8+ killer cells. A TH2 cell on the other hand can stim-
ulate a B cell that recognized the antigen in question by its membrane bound
antibody, inducing proliferation, antibody class switch and higher antibody pro-
duction. This secreted specific antibody now enables enhanced phagocytosis of
antibody-opsonized antigen and antibody dependent cell cytotoxicity (ADCC),
both performed by macrophages.
The development of these cells is influenced in an autocrine/paracrine fashion
mediated through the impact of numerous cytokines, chemokines and growth
factors. The TH1 cells develop under the influence of interferon- (INF)-γ, tumor
necrosis factor- (TNF)-α, and interleukine (IL)-2. They, themselves, produce
INF-γ, which stimulates DCs and macrophages to produce IL-12, which in turn
up-regulates INF-γ production by T cells, resulting in a positive feedback loop.
The TH2 cells develop under the influence of IL-4, IL-5, IL-6, IL-10 and IL-13.
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TH2 cells produce IL-4, which is auto-regulatory, and IL-10, which inhibits INF-
γ and IL-2 production by T cells and IL-12 production by DCs and macrophages.
These positive feedback loops ensure progress in the direction, whether TH1 or
TH2, which was initially chosen. The factors leading to this decision are not
entirely clear. They depend on the phenotype of the activating APC and the
factors present within the microenvironment.
1.1.5 DC and macrophage activation
Recognizing and subsequently binding an antigen are sufficient stimuli for the
immature DC to maturate. The mature DC expresses high levels of MHC
class II and costimulatory molecules, and migrates to the next lymph node.
This anatomic architecture of the adaptive immune system offers the greatest
possibility for the APC to meet a specific, na¨ıve T cell. After a mature DC
activates a T cell, the T cell needs no further activation signals.
For macrophage activation, on the other hand, three distinct activation modi
have been described: the ’classical’ macrophage activation, the ’alternative’
macrophage activation and the more recently proposed ’type 2’ macrophage
activation (Edwards et al., 2006)
Classical macrophage activation The classical activation pathway is the longest
known and by far best characterized (Adams and Hamilton, 1984; Gordon,
1998). It is a two-step process in which the macrophage is primed prior to
being activated. For example, the macrophage is primed by INF-γ before it is
exposed to TNF-α or a stimulus inducing TNF-α. A very potent stimulator of
TNF-α secretion is lipopolysaccharide (LPS), a component of the cell wall of
Gram-negativ bacteria (Morrison and Ryan, 1979). Although there are many
variants of LPS, all of them have a constant region termed lipid A, which alone
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can reproduce all the biological effects of LPS. This activation process takes
three steps: first a secreted LPS binding protein (LPB) binds to LPS. This
complex is recognized by membrane bound CD14 (Wright et al., 1990), which
cannot be activated by lipid A alone (Tobias et al., 1999). Because CD14 does
not have a cytoplasmatic domain, this complex must be delivered to a signal
protein of the Toll like receptor (TLR) family as the last step. Experiments
in mice have shown that deletion of the genes encoding for LPB or CD14 does
only reduce the responsiveness to LPS. In contrast, mice without the TLR4
gene show a total loss of LPS reactivity (Poltorak et al., 1998). This indicates
the great importance of this third step (Janeway and Medzhitov, 2002). This
classical macrophage activation induces the production of reactive oxygen and
nitrogen radicals, which enable the macrophage to kill intracellular microorgan-
isms. Further, classically activated macrophages produce IL-12, directing the
T cell response towards the T helper type 1 (TH1) response.
Alternative macrophage activation About 17 years ago, Stein et al. (Stein
et al., 1992) described a functionally and biochemically distinct activated mac-
rophage phenotype resulting from stimulation with the TH2 cytokine IL-4. This
alternatively activated macrophage is characterized by the production of IL-
10 and IL-1 receptor antagonist, and low antigen presenting capacity towards
T cells (Gordon, 2003). Furthermore, production of matrix-associated proteins
and promotion of fibrogenesis by these cells was suggested to be possible con-
tributing factors in wound healing and tissue repair (Albina et al., 1990; Song
et al., 2000). In the mouse model, it could be shown that the differentiation
of monocytes into fibrocytes is regulated by CD4+ T cells (Niedermeier et al.,
2009). This phenotype change in alternative macrophage activation is epigenet-
ically regulated (Ishii et al., 2009).
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Type 2 macrophage activation A third type of activated macrophage popu-
lation can be generated by stimulation of macrophages with classical activation
signals in the presence of immunoglobuline (Ig)G containing immune complexes
(Sutterwala et al., 1998). TLR as well as CD40 activation after ligation of
receptors for the Fc fragment of IgG (FcγR) resulted in suppression of IL-12
production and a strong induction of IL-10 (Mosser, 2003). This turns these
type 2 activated macrophages into potent anti-inflammatory cells (Gerber and
Mosser, 2001). They also stimulate the production of TH2 cells, which produce
high levels of IL-4 (Anderson and Mosser, 2002).
Not activated macrophages Macrophages very important in the removal of
apoptotic cells but do not activate T cells that recognize apoptotic body- associ-
ated antigens (Henson and Hume, 2006). It has been shown that macrophages,
in contrast to DCs, mediate anergy in T cells. This results suggest that, dur-
ing non-inflammatory conditions, macrophages which phagocytose mainly self-
peptides, mediate anergy in T cells that recognize the self-peptides presented
on a MHC class II molecules, thus helping in maintaining peripheral tolerance
(Hoves et al., 2006). Brem-Exner et al. (Brem-Exner et al., 2008) identified
INF-γ-stimulated monocyte derived cells in the mouse model which have cer-
tain T cell-supressive effects with potential therapeutic benefit in the treatment
of autoimmune inflammations.
1.2 The macrophage: origin and differentiation
Elie Mechnikoff described more than 100 years ago a large mononuclear phago-
cytic cell and named it ’macrophage’ (Karnovsky, 1981). After the discovery of
different phagocytic cells in various tissues of the body, the idea of a reticulo-
endothelal system (RES) was postulated in 1924 by Aschoff (Aschoff, 1924).
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Because the RES contained cells not belonging to the mononuclear lineage, van
Furth proposed the mononuclear phagocyte system (MPS) (van Furth, 1982).
The MPS comprises myeloid progenitor cells that differentiate into blood mono-
cytes, which circulate and extravasate to become tissue macrophages. The dif-
ferent macrophage subtypes in various tissues are listed in table 1.1. In the clas-
sical sense, cell divisions in this lineage occur in the monoblast and promonocyte
stages and the pool of macrophages in the periphery is renewed by circulating
monocytes rather than by local cell division. This paradigm has been challenged
as recent findings show at least a small percentage of cell renewal by local cell
division under steady state conditions (Tacke and Randolph, 2006) and evidence
exists, that M-CSF can induce proliferation in monocytes (Clanchy et al., 2006).
Recently, several authors proposed, that the model of the MPS might have out-
lived its usefulness, as there might be as many different macrophage subtypes
as markers applied for their description (Hume, 2006, 2008). They claim that
beside differentiated DC and osteoclasts, all macrophages can change as a conse-
quence of their microenviroment, continuosly adapting their functional pattern
in response to the progressive inflammatory response (Stout and Suttles, 2004;
Stout et al., 2005, 2009).
The origin of the DCs and the connections to the monocyte lineage are still not
entirely clear (Ardavin et al., 2001; Leon et al., 2005; Fogg et al., 2006). There is
evidence that DCs can be generated in vitro from both, myeloid and lymphoid
progenitors, but it’s not sure, whether there are physiologic counterparts for this
in vitro generated subtypes. A common precursor for macrophage and DC was
proclaimed by Fogg et al. (Fogg et al., 2006). If there are distinct myeloid and
lymphoid DC subsets or if there is just a continuum between two extremes is
still point of discussion (Hume et al., 2002; Hume, 2006, 2008).
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Tissue Cell
Bone marrow Monoblasts
Promonocytes
Monocytes
Macrophages
Peripheral blood Monocytes
Liver Kupffer cells
Lung Alveolar macrophages
Connective tissue Histiocytes
Spleen Red Pulp Macrophages
Lymph node Macrophages
Thymus Macrophages
Bone Osteoclasts
Synovium Type A Cells
Mucosa-associatied lymphoid tissue Macrophages
Gastrointestinal tract Macrophages
Central nervous system Microglia
Skin Histiocytes/ Langerhans cells
Serous cavities Pleura/Peritoneal macrophages
Inflammatory tissues Epitheloid cells
Exudative macrophages
Granuloma Multinucleated giant cells
Table 1.1: Mononuclear phagocytes in different tissues,
adapted from (Ross and Auger, 2002)
1.2.1 Differentiation from stem cell to monocyte
The origin of the blood monocyte is a pluripotent stem cell in the bone marrow,
dependent on stem cell factor (or c-Kit ligand). The next step in differentiation
is the common myeloid progenitor for erythrocytes, neutrophiles and monocytes,
followed by the granulocyte-monocyte colony-forming unit, which can still dif-
ferentiate into neutrophiles and monocytes. Under the influence of granulocyte-
monocyte colony-stimulating factor (GM-CSF) and macrophage CSF (M-CSF)
the monoblast differentiates past the premonocyte point to monocytes, the first
cell population that enters the blood.
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1.2.2 Monocyte classification
Blood monocytes are not a homogeneous population, but show at least two
distinct subtypes, a CD14high CD16− ’inflammatory’ monocyte and a CD14low
CD16+ ’resident’ monocyte (Passlick et al., 1989; Gordon and Taylor, 2005).
The minor CD16+ monocyte subgroup seems to contain an ’intermediate’ CD14+
CD16+ CD64+ monocyte subgroup (Grage-Griebenow et al., 2001b), which has
a high phagocytic activity and produces large amounts of cytokines comparable
to the ’classical’ monocytes, but show high expression of CD86 and HLA-DR and
a stimulatory activity in mixed leukocyte reactions comparable to DCs (Grage-
Griebenow et al., 2001a). Both human monocyte subtypes can differentiate in
vitro in the presence of GM-CSF and IL-4 into DCs (Sanchez-Torres et al., 2001).
In a mouse model of transendothelial trafficking the CD14+ CD16+ monocyte
subset differentiated to DC more likely than the CD14high CD16− monocyte sub-
set (Randolph et al., 1998). The transcriptional profile of the CD16+ monocytes
suggests a more advanced stage of differentiation compared to CD16- monocytes
(Ancuta et al., 2009). The physiological role of this monocyte subtypes remains
unclear, as the performed in vitro experiments do not allow a direct transfer to
the in vivo situation.
The identification of mouse counterparts of the human monocyte subsets
have contributed to the understanding of their function in vivo. Geissmann
et al. (Geissmann et al., 2003) have described two monocyte subsets with dis-
tinct homing potential in the mouse. The mouse Gr-1+ CCR2+ CX3 CR1lo
monocyte subset, correspond to the human CD14high CD16− monocyte subset,
and a Gr-1− CCR2− CX3 CR1hi monocyte subset, correspond to the human
CD14lo CD16+ monocyte subset. They showed, that the Gr-1+ CX3 CR1lo
subset is recruited preferentially to inflammatory sites, and that the Gr-1− CX3
CR1hi subset serves as a precursor of resident myeloid cells. Sunderko¨tter et
9
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al. (Sunderkotter et al., 2004) have claimed that the different monocyte subsets
in mouse are developmentally connected. They hypothesized that monocytes
leave the bone marrow as Gr-1hi cells and mature over an intermediate Gr-1med
stage to the Gr-1lo monocytes. They showed that after complete depletion only
Gr-1hi monocytes repopulate the blood, and Gr-1lo monocytes are seen on day
7 first. They confirmed the findings of Geissmann et al. (Geissmann et al.,
2003), in that Gr-1hi monocytes are recruited preferentially to inflammatory
sites, and showed furthermore that during inflammation Gr-1hi monocytes are
released into the blood, analogous to the left shift seen also with granulocytes.
Ginhoux et al. (Ginhoux et al., 2006) further showed that Gr-1hi monocytes
could give rise to Langerhans cells (LCs) and macrophages in inflamed skin in
vivo, confirming the in vitro findings that monocytes can differentiate into both,
macrophages and DCs, at least under inflammatory conditions. In the lung the
two distinct monocyte populations Gr-1hi and Gr-1lo give raise to two distinct
tissue DC populations (Jakubzick et al., 2008). Using this mouse model, Liu
et al. (Liu et al., 2009) depict a procursor-progeny relationship of monocytes,
classical spleen (c)DCs and plasmacytoid (p)DCs. Starting with a myeloid pro-
genitor that gives rise to macrophage and DC progenitors (MDPs) which can
differentiate to monocytes or common DC progenitors (CDPs). This CDPs gen-
erate pre-cDCs and pDCs. They point out that monocytes do not develop into
cDCs and contribute little to lymphoid-organ DC network in steady state con-
ditions. They define the point of divergence between multipotential precursors
and pre-cDCs in the bone marrow, from where the latter migrate through the
blood to lymphoid tissues, where they divide and fill the DC compartment. For
the DC network in the lamina propria of the gut this findings lead to the idea
of a dual origin of DCs in the steady state. It consists of DCs derived from
monocytes and pre-cDCs. The DCs that arise from pre-cDCs are addressed as
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the key sentinels of the gut immune system (Bogunovic et al., 2009; Varol et al.,
2009).
Reports that the human CD14lo CD16+ monocyte subset is elevated in sepsis
(Skinner et al., 2005), rheumatoid arthritis (Kawanaka et al., 2002b) chronic
renal failure (Kawanaka et al., 2002a; Saionji and Ohsaka, 2001), cancer (Saleh
et al., 1995), tuberculosis and HIV infection (Grage-Griebenow et al., 2001a)
lead to the idea that this subtype is ’inflammatory’. Taken into account that
the mouse counterparts, the Gr-1lo monocytes do not migrate to sites of inflam-
mation in vivo (Geissmann et al., 2003; Sunderkotter et al., 2004), this term has
to be re-evaluated.
1.2.3 Experimental models of monocyte differentiation
Since macrophages and DCs are difficultly to obtain from human donors in the
required amounts, these cells have to be generated in vitro for further analyses.
Several in vitro systems to differentiate them from blood monocytes have been
developed. When the first researchers started to work with human monocytes,
they soon realized that adhesion is a very important keystone for monocyte
survival and differentiation, but still not sufficient without human serum (Becker
et al., 1987). Investigators then tried to define the biochemical factors present
in human serum that lead to monocyte maturation. Many chemicals have been
identified, either by using purified or recombinant proteins, or by inhibition
of known molecules with specific monoclonal inhibitory antibodies. It could,
for example, be shown that M-CSF is a critical factor for monocyte survival as
the treatment of adherent cultures with human serum in the presence of anti-M-
CSF antibodies inhibited monocyte maturation (Andreesen et al., 1990; Brugger
et al., 1991). On the other hand, M-CSF alone is not a sufficient replacement for
human serum. Recently Way et al. (Way et al., 2009) described two serum-free
11
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M-CSF containing cytokine cocktails to generate monocytes and macrophages
from human CD34+ hemopoietic stem cells.
1.2.4 The impact of monocyte adhesion
Before a blood monocyte becomes a differentiated macrophage, it leaves the bone
marrow and circulates in the blood, adheres to the endothelium of a blood vessel
and transmigrates into the surrounding tissue. This involves an initial selectin-
glycoprotein interaction, resulting in monocyte rolling. Then, the monocyte
integrins have to be activated by chemokines, allowing a firm integrin-protein
adhesion. Following cell polarisation, the monocyte can migrate by diapedesis
between the epithelial cells into the subendothelial extracellular matrix (ECM)
(Imhof and Aurrand-Lions, 2004). Although there are many chemokines known
to induce leucocyte adhesion under inflammatory conditions (Cravens and Lip-
sky, 2002), little is known about the constitutively expressed chemokines lead-
ing to monocyte adhesion in non-inflammatory conditions (Imhof and Aurrand-
Lions, 2004).
The recent findings about different monocyte sub-populations in mice suggest
an inflammatory and a non-inflammatory monocyte subset, and confirm the idea
that macrophages in the periphery are replenished by circulating blood mono-
cytes (see 1.2.2). The origins of the many diverse forms of macrophages seen in
various tissues are not mature forms of different monocyte sub-populations but
rather multiple phenotypic manifestations of monocytes reflecting tissue-specific
ECM and the local biochemical microenvironment. Once a monocyte enters a
tissue, it soon becomes indistinguishable from the resident macrophages (Hume,
2006).
So, the cell-cell and cell-matrix contacts can be suspected to have an im-
pact on monocyte differentiation. Integrin ligation causes an ”outside-in” signal
12
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involving many transcription factors controlling complex functions like cell po-
larisation and migration. Some of these transcription factors induced by integrin
engagement are also involved in monocyte survival and differentiation (Shi and
Simon, 2006). In vitro experiments using various ECM molecules showed that
fibronectin seems to induce stronger monocyte to macrophage differentiation
than collagen I or collagen IV (Jacob et al., 2002).
Recent results from this group have clearly demonstrated that monocyte ad-
hesion could inhibit apoptosis. This is most likely due to adhesion-induced
secretion of M-CSF, which acts subsequently in a autocrine manner (Mondal et.
al, unpublished data). Inhibition of apoptosis following monocyte transmigra-
tion through epithelia was confirmed by Williams et al. (Williams et al., 2009).
Similar results were found for polymorphonuclear leukocytes, where transmigra-
tion inhibited apoptosis (Hu et al., 2004).
Monocyte adhesion and subsequent integrin engagement results in ”outside-
in” integrin signaling, causing tyrosine phosphorylation of certain intracellular
proteins, namely ERK, p38 and JNK. This results in rapidly activated transcrip-
tion, stabilization of the produced mRNA and organization of the cytoskeleton
(Mondal et al., 2000). To what extent this tyrosine phosphorylation cascade is
affecting the monocyte differentiation is incompletely defined. Recently, Shi et
al. (Shi and Simon, 2006) pointed out the role of the forkhead transcription fac-
tor Foxp1 in monocyte differentiation. On the other hand, Himes et al. (Himes
et al., 2006) displayed the interaction of the JNK and M-CSF, thus indicating a
synergic effect of both, M-CSF and adhesion, on monocyte differentiation. M-
CSF in this context is also known to promote macrophage motility in addition
to adhesion to extracellular matrix (Rovida et al., 2005).
The firm adhesion to plastic could prevent monocytes in serum free cultures
from cell death, through the production of autocrine survival factors like M-
13
1 Introduction
CSF and TNF-α (Haskill et al., 1988). The not-so-firmly-adherent moncytes
on Teflon foils could be rescued from apoptosis in serum free medium only with
additional M-CSF. Under both conditions and similar on other surface coatings,
monocyte survival was never accompanied with differentiation under serum free
conditions (Andreesen et al., 1990).
1.2.5 The role of M-CSF and its receptor
Since the first description of M-CSF and its receptor many effort has been made
to elucidate the biochemical structures and the intra-cellular signal cascades
that in the end lead to morphologic changes in the monocyte.
M-CSF is a disulfide-linked homodimer and is expressed by many cells in three
isoforms: secreted glycopeptide and peptidoglycan that are synthesized by en-
dothelial cells and enter the circulation, and a membrane bound cell-surface
glycopeptide which is involved in local regulation. The secreted peptidoglycan
can also act locally by binding to extracellular matrices (Chitu and Stanley,
2006). Macrophages derived from monocytes after 5 days in culture constitu-
tively produce M-CSF (about 15 ng/ml) for at least 28 day (Scheibenbogen and
Andreesen, 1991).
The M-CSF receptor seems to be restricted to monocytes and their precursors,
macrophages, DCs and osteoclasts and the female reproductive tract (Sasmono
et al., 2003). The M-CSF receptor is a receptor tyrosin kinase and closely related
to the c-Kit receptor. Binding of M-CSF to its receptor results in non-covalent
dimerization of the M-CSF receptor, activation of its kinase and a first wave
of M-CSF receptor tyrosine phosphorylation. After covalent dimerization and
a second wave of tyrosine phosphorylation, affecting about 0.02 % of the total
cellular protein, the ligand-receptor complex gets ubiquitinated and lysosomal
degraded (Stanley et al., 1997; Pixley and Stanley, 2004).
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In vitro results
In early experiments to generate macrophages in vitro, M-CSF, at least in physi-
ological serum concentrations, was found to be obligatory for monocyte survival
and differentiation, as monocytes die in serum free media or if M-CSF was de-
pleted from serum by neutralizing antibodies (Becker et al., 1987; Andreesen
et al., 1990; Brugger et al., 1991). Macrophages need continuos M-CSF, as the
removal of this cytokine results in apoptosis (Komuro et al., 2005). Several fac-
tors related to monocyte or macrophage survival, for example adhesion (Mondal,
unpublished data) induce autocrine M-CSF production, but also M-CSF itself
induces the production of survival and differentiation factors (Komuro et al.,
2005). M-CSF could also induce proliferation in a monocyte subset (Finnin
et al., 1999).
In vivo results
Many insights to the in vivo function of M-CSF were gained using a osteopetrotic
mouse model, which is deficient for M-CSF (Csf1 op/op). These mice show normal
blood monocyte counts but a reduced number of almost all tissue macrophages
populations, which could be restored by daily intracutaneous M-CSF injection
(Stanley et al., 1997; Chitu and Stanley, 2006) or by using M-CSF transgenes
for the different isoforms (Ryan et al., 2001; Dai et al., 2004; Nandi et al.,
2006). In contrast, Csf1 op/op mice have fully differentiated DCs and LCs, which
lead to the hypothesis that these cells develop independently from mononuclear
phagocytes (Wiktor-Jedrzejczak and Gordon, 1996).
However, using a mouse model deficient for the M-CSF receptor (Csf1r -/-),
Ginhoux (Ginhoux et al., 2006) showed, that LCs development in the epider-
mis is dependent on M-CSF and that under inflammatory conditions LCs can
arise form monocytes in vivo. Furthermore, MacDonald (MacDonald et al.,
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2005) showed that the M-CSF receptor is upregulated in all DC subsets dur-
ing differentiation, supporting the idea that most tissue DCs are of myeloid
origin. Recently could be shown that the DC favoring cytokine GM-CSF and
IL-4 in combination up-regulate the TNF-α converting enzyme expression and
activity, causing ectodomain shedding of the membrane-bound M-CSF receptor
and thereby directing the monocyte towards a DC like phenotype (Hiasa et al.,
2009).
M-CSF in diseases
Blood levels of M-CSF are elevated in several diseases. High levels were found
in patients undergoing dialysis (Saionji and Ohsaka, 2001) and during acute
renal allograft rejection in human (Le Meur et al., 2004) and mouse (Le Meur
et al., 2002). The latter proposed using M-CSF as a specific marker of acute
allograft rejection. M-CSF seems also to be elevated in severely ill trauma pa-
tients, where it possibly impairs the immunological defense (De et al., 2003). In
cancer, especially of the female reproductive tract, increased circulating M-CSF
can be found (Kacinski, 1997). In this and other neoplasias, so called tumor-
associated macrophages seem to have a two edged role: promotion of tumor
invasion via macrophage recruitment by the secreted M-CSF versus the stimu-
lation of direct killing and antigen-processing by the cell-surface M-CSF (Chitu
and Stanley, 2006). This offers also therapeutic options, as M-CSF blockade by
antisense oligonucleotides and small interfering RNAs can suppress the growth
of human mammary tumor xenografts in mice (Aharinejad et al., 2004). In
rheumatoid arthritis, where macrophages play an important role (Hamilton and
Tak, 2009) elevated levels of M-CSF are correlated with an increased number
of CD14loCD16+ monocytes (see above), thus indicating that M-CSF may con-
tribute to this more mature monocyte subset in the blood (Kawanaka et al.,
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2002b). Monocytes of severely injured trauma patients do not differentiate into
DC under appropriate stimuli as a sign of previous differentiation into a more
macrophage-like cell type caused by enhanced M-CSF responsiveness (De et al.,
2003). M-CSF release by endothelial vascular cells is up-regulated by C reac-
tive protein inducing macrophage proliferation causing atherosclerosis (Devaraj
et al., 2009; Irvine et al., 2009). Several therapeutic strategies targeting M-CSF
are now in preclinical studies or phase I clinical trials (Hamilton, 2008).
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2 Prework and aims
Various ways have been described to cultivate and differentiate human peripheral
blood monocytes, for example into macrophages or DCs. All of them share an
adherent culture condition. As cells of the monocytic lineage exist also in body
fluids (see table 1.1), differentiation may occur physiologically also under non-
adherent conditions. Although a lot of research has been published concerning
the intracellular changes caused by monocyte adhesion, up to now little is known
about the impact of adhesion on monocyte differentiation. To approach this,
we used an experimental setting developed by members of this group and first
published by Arndt (Arndt et al., 2007) to culture monocytes non-adherently.
It could be shown that monocytes undergo apoptosis within 3 days if culturing
them in a continuously rotating culture system that inhibits cell adhesion. This
apoptosis could be inhibited by a one-time addition of exogenous M-CSF at
the beginning of the culture period. As adhesion is inducting the secretion of
M-CSF, this led to the hypothesis that adhesion inhibits apoptosis through the
autocrine action of M-CSF (Mondal et al., unpublished data).
First aim of this study was to quantify the survival rate of this M-CSF in-
duced non-adherently cultured monocytes (MMAC) and to compare it to that of
adherently generated macrophages (MAC). Second aim was to validate whether
these MMAC had differentiated. To this end, their phenotype was character-
ized in detail using monoclonal antibodies and flow cytometry. Their functional
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properties were determined in terms of phagocytosis, antigen presentation and
cytokine production. The results were compared to those of MAC and immature
monocyte derived dendritic cells (DC). To determine the influence of M-CSF,
they were also compared to monocytes that were cultivated adherently with
additional M-CSF (MAC + M-CSF). The experiments were performed under
donor matched conditions, in that all DC, MMAC, MAC + M-CSF and MACs
were generated in parallel from freshly isolated monocytes from the same donor
to minimize donor dependent variation of survivability or differentiation char-
acteristics.
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3.1 Basic techniques
3.1.1 Media and solutions
The compositions of the frequently used media and solutions are provided in
the appendix, table 7.1. A list of all companies is also given there in table 7.2.
3.1.2 Sterile protocols
All work with cell cultures and functional analyses were carried out under sterile
conditions, using a laminar air flow work bench (Hareus) and sterile single use
pipettes. If not otherwise declared, cell centrifugation was performed at 300 g
using a table centrifuge (Hareus) and centrifuge tubes (Falcon) with 15 ml or
50 ml. Strictly sterile protocols were used to prevent any nonspecific activation
of the cells.
3.1.3 Cell culture conditions
All cells for long term culturing and for short term functional analyses were
incubated in an incubator (Hareus) at a constant temperature of 37◦C, with a
95 % humidity and 5% CO2 concentration.
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3.1.4 Viable cell count using trypan blue
To determine the number of viable and dead cells, the vital dye trypan blue
was used. Trypan blue is actively excluded by living cells and stains dead cells
with damaged membranes blue. For this, 50 µl of cell suspension were added to
50 µl of trypan blue solution (table 7.1). Cells were counted under a microscope
(Axiovert 25, Zeiss) at 100× magnification, using a Neubauer counting chamber
as hemacytometer. For accuracy all four 1 mm2 quadrants were counted and
the cell number was calculated according to the following formula:
Cellcount =
N
4
·D · 104 ml−1
N = cell number, D = dilution factor
3.2 Monocyte isolation through counter-current
elutriation
Leukocyte enriched blood was obtained via leukapheresis (Graw et al., 1971)
form healthy volunteers. Mononuclear cells (MNC) were isolated from this leuka-
pheresis concentrates by density gradient centrifugation over Ficoll-Hypaque
(Pharmacia) (Johnson et al., 1977). Monocytes were separated from MNC
by counter-current elutriation (Sanderson et al., 1977) in a J6M-E centrifuge
(Beckman) with a 50 ml chamber and a JE-5 rotor. Initially, the centrifuge was
sterilized with 6% H2O2 in H2O for 20 minutes and washed two times with PBS
(PAN).
The variable pump was calibrated with Hanks’ balanced salt solution (PAN)
at constant 1100 g and 4◦C. MNCs were given into the system at a flow rate
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fraction flow rate main cells in the fraction
(ml/min)
1a 52 thrombocytes
1b 57 small lymphocytes
2a 64 intermediate lymphocytes
2b 74 intermediate lymphocytes
2c 92 big lymphocytes
3 111 monocytes
Table 3.1: Elutriation parameters and corre-
sponding cell fractions
of 52 ml/min, followed by continuous infusion of Hanks’ solution supplemented
with 6 % autologous plasma. The flow rate was increased step by step following
the scheme displayed in table 3.2 and monocytes as the largest cells in the MNC
fraction were collected in the last fraction 3. These elutriated monocytes were
more than 80% pure as determined by morphology and by the expression of the
CD14 antigen (table 3.2), measured by flow cytometry (3.5).
3.3 Monocyte culture conditions
Because monocytes show a great donor dependent variability, MMAC, MAC,
DC and MAC + M-CSF were prepared in parallel cultures from each donor.
3.3.1 Classical monocyte derived macrophages (MAC)
Monocytes were cultured at a cell density of 1·106 cells/ml in hydrophobic Teflon
bags for 7 days in macrophage media (table 7.1) (Andreesen et al., 1983). To
harvest the adherent macrophages from the Teflon bags, they were cooled for
15 minutes at 4◦C and then loosened by gently tapping the cells off the Teflon
while leaving the plasma membrane intact.
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3.3.2 Monocyte derived dendritic cells (DC)
Monocytes were cultured at a cell density of 1·106 cells/ml in vented flasks
(Costar) for 7 days in DC media (table 7.1) with 6 pg/ml IL-4 (Immunotools)
and 50 pg/ml GM-CSF (Essex). Only the non-adherent cells were harvested
(Sallusto and Lanzavecchia, 1994).
3.3.3 Non-adherently cultured monocytes (MMAC)
In order to establish an in vitro system to culture monocytes under absolute
non-adherent conditions, we used a system described by Arndt et al. (Arndt
et al., 2007) in which monocytes were cultured in a continuously rotating (12
U/min) flask (250 ml centrifuge tubes, Falcon) with a vented cab (Costar),
using a Universal Turning Device (Greiner Bio-one). The cells were seeded at a
density of 1·106 cells/ml in macrophage medium (table 7.1) supplemented with
100 ng/ml recombinant human M-CSF (Cetus) and cultured for 7 days. For
further processing, these cells had to be handled on ice to avoid adhesion to the
plastic containers.
3.3.4 Adherently cultured monocytes with additional M-CSF (MAC
+ M-CSF)
Monocytes were cultured and harvested according to the same protocol as for
MAC (see 3.3.1) with additional 100 ng/ml recombinant human M-CSF (Cetus)
analogous to MMAC (see 3.3.3.
3.4 Light microscopy and photographs
For photographs, unstained cells were prepared seperately. To demonstrate cell
morphology under non-adherent conditions, pictures of MMAC, MAC and MAC
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+ M-CSF were taken immediately after harvesting, by suspending large droplets
of cells on a small Teflon foil to prevent cell adhesion. Pictures of MAC and
MAC + M-CSF were also taken adherent on Teflon prior to harvesting. Light-
microscopic examinations were done using an Axiovert 25 microscope (Zeiss)
and a Finepix S1 pro camera (Fujifilm) for photographs. The photographs were
edited for printing with the freely available software ”The GIMP”.
3.5 Flow cytometry
Antigen Label Isotype Clone Company
primary antibodies (all from mouse):
Isotype FITC IgG1 X40 BD Biosciences
Isotype FITC IgG Beckman Coulter
Isotype PE IgG1 X40 BD Biosciences
Isotype PE IgG2b MPC-11 BD Biosciences
Isotype none IgG1
CD 1a PE IgG1 BL6 Beckman Coulter
CD 14 FITC IgG2a Mµ4 Beckman Coulter
CD 16 FITC IgG2a 5D2 PeliCluster
CD 40 PE IgG1 5C3 BD Pharmingen
CD 71 FITC IgG1 YDL.1.2.2 Immunotech
CD 80 PE IgG1 L307.4 BD Pharmingen
CD 84 PE IgG1 2G7 BD Pharmingen
CD 86 FITC IgG1 2331 (FUN-1) BD Pharmingen
HLA-DR FITC IgG1 B-F1 Diaclone
HLA-ABC PE IgG1 G46-2.6 BD Pharmingen
DC-SIGN PE IgG2b DCN46 BD Pharmingen
MAX.11 none IgG1 own lab (Rehli et al., 1995)
secondary antibody (from goat):
anti-mouse FITC IgG+M Jackson ImmunoResearch
Table 3.2: Antibodies used for flow cytometry. Conjugated fluo-
rochromes: flouresceinisocyanat (FITC) or phycoerythrin (PE).
The phenotype of the cells was determined by flow cytometry using a fluorescent-
activated cell sorter (FACS). Flow cytometry allows the measurement of the
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fluorescence of a single cell or particle, in contrast to related techniques like
spectrometry, where only the absorption and transmission of the whole sample
can be determined. In short, a stream of fluid containing cells flows through the
machine such that a single cell at a time passes by a light source. Here the cells
intercept with light of a certain wavelenght, usually from a laser source. As the
beam hits a cell, only a part of the light passes unaffected, which is detected as
forward scatter (FSC) and corresponds to the size of the cell. The part that is
reflected 90◦ off is detected as sideward scatter (SSC) and corresponds to cell’s
complexity and granularity. If the cell or particle has fluorescent properties,
the light beam can excite these fluorochrome molecules to emit photons of the
wavelength characteristic for the fluorochrome. For example, fluorescein iso-
cyanat (FITC) emits light between 500-550 nm wavelength and phycoerythrin
(PE) emits from 550-650 nm wavelenght. By using detectors with different
wavelength filters, fluorochromes with different wavelenghts can be detected si-
multaneously. The sensitivity of the detectors, which most commonly are photo
multiplier tubes (PMT), can be adjusted by changing their voltage. The data
of many events (usually 20,000) is stored in a computer and can be visualized
logarithmically as histogram or dot plot. To compare the results of different
experiments, the mean fluorescent intensity (MFI) is calculated in every his-
togram.
To prepare the cells for flow cytometry, they were centrifuged at 300 g for
5 minutes at 4◦C and washed 2 times with FACS washing buffer (table 7.1). The
human immunoglobulins present in the FACS washing buffer serves to block the
cells’ endogenous Fc-receptors and thus to minimize the non-specific binding of
the subsequently used antibodies. After the first washing step, the cells were re-
suspended to 5·105 cells/ml and about 2.5·105 cells each were evenly distributed
to 5 ml polystyrene tubes (Falcon) for FACS analysis. After another centrifuga-
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tion, the supernatant was decanted and the pellet loosened. The cells were then
incubated with saturating amounts of specific antibody or an isotype control
(see table 3.2) for 30 min at 4◦C in the dark, followed by two washing steps
with FACS washing buffer. In case of an un-conjugated antibody, the cells were
incubated with 50 µl secondary antibody (FITC conjugated goat-anti-mouse)
for another 30 minutes. After two final washing steps all cells were fixed in
200 µl FACS fixative (table 7.1). The cells were single stained only. Instru-
ment settings were set so that the isotype control fell in the first decade. The
results were displayed logarithmically as histograms. The cells were analyzed
between 24-48hrs using a FACSCalibur flow cytometer (Becton-Dickinson). All
data were analyzed with the CellQuest software (Becton-Dickinson), using the
forward scatter (FSC) and sideward scatter (SSC) to gate cell debris out.
3.6 Short description of the detected antigens
Freshly isolated monocytes, MAC and MMAC after 3 days in culture and MAC,
MMAC, DC and MAC + M-CSF after 7 days were stained for the following
markers: antigens typically associated with either macrophage or DC differen-
tiation and antigens that are expressed on both macrophage and DC, reflecting
their function as antigen presenting cells and therefore involved in antigen up-
take and T cell activation.
3.6.1 Antigens of macrophage differentiation: CD14, CD16, CD71,
CD84 and MAX.11
CD14 is important for the reaction of the organism to LPS. It acts as a receptor
for LPS bound to LBP (Wright et al., 1990) and is expressed on monocytes
and macrophages (Todd et al., 1981). CD14 is membrane bound but lacks
a cytoplasmic domain. Thus it needs the Toll like receptor 4 (TLR4) as a
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coreceptor to trigger the signal cascade leading to TNF-α release (Poltorak
et al., 1998).
CD16 or FcγIII is a low-affinity receptor for monomeric IgG. It is developmen-
tally up-regulated in the in vitro differentiation from monocyte to macro-
phage (Clarkson and Ory, 1988; Andreesen et al., 1990). Although it was
initially thought to be restricted to differentiated macrophages, a mono-
cyte subpopulation expressing CD16 has been described (Passlick et al.,
1989).
CD71 or transferrin receptor is a differentiation marker for macrophages and
not present on monocytes (Andreesen et al., 1990). It is also expressed on
intestinal DC and on monocyte derived DC where it acts as a receptor for
IgA (Pasquier et al., 2004).
CD84 is a member of the CD2 subgroup of Ig super-family (de la Fuente et al.,
1997). It is identical to the antigen recognized by the MAX.3 antibody and
is a glycoprotein expressed on mature macrophages (Krause et al., 2000).
Although MAX.3 bound only to mature macrophages, other anti-CD84
monoclonal antibodies detecting distinct epitopes showed a weak expres-
sion on monocytes and DC (Zaiss et al., 2003). It is a co-stimulatory
molecule and binds to itself, thus enabling contact between APC and
T cell. The CD84-CD84 connection inducts INF-γ secretion (Martin et al.,
2001).
The MAX.11 antibody recognizes Carboxypeptidase M (Rehli et al., 1995; Krause
et al., 1998), a surface molecule characteristic for monocyte to macrophage
differentiation (Andreesen et al., 1986).
28
3.6 Short description of the detected antigens
3.6.2 Cell surface antigen of DC differentiation: CD1a
CD1a is an antigen-presenting molecule distantly related to the MHC class I
molecules (Martin et al., 1986; Blumberg et al., 1995; Banchereau et al.,
2000). It binds non-peptic self and foreign molecules and presents them
to T cells (Dutronc and Porcelli, 2002). Thus it contributes not only to
host immunity but also to autoimmune and anti-tumor reactions (Hunger
et al., 2004). CD1a is a good marker for in vitro generated blood-monocyte
derived DCs (Sallusto and Lanzavecchia, 1994) and epidermal Langerhans
cells (Fithian et al., 1981).
3.6.3 Functional antigenes of antigen presenting cells: CD40,
DC-SIGN, CD80/CD86, HLA-ABC and HLA-DR
CD40 is a member of the TNF-receptor super-family and is present on all APCs,
particularly on DCs (Rogers et al., 2003). It is critical for presentation
to and induction of cytotoxic T cells. CD40 is known to be induced after
activation of PRRs like the TLRs. Activation of CD40 by its ligand CD40L
results in up-regulation of the co-stimulatory CD80 and CD86 and MHC
class II via the transcription factor nuclear factor (NF)-κB (O’Sullivan
and Thomas, 2003).
CD209 or DC-SIGN (DC-specific ICAM3-grabbing non-integrin) is a C-type
lectin receptor for intercellular adhesion molecule (ICAM) 3 and ICAM2
(Geijtenbeek et al., 2000). Furthermore it can act as a PRR and provide a
mechanism for pathogens, particularly HIV, to evade the immune surveil-
lance (van Kooyk and Geijtenbeek, 2003). It is constitutionally expressed
on DCs and macrophages (Soilleux et al., 2002).
CD80 and CD86 or B7-1 and B7-2 are co-stimulatory molecules associated with
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APC - T cell interaction. Their counter ligands on T cells are CD28 and cy-
totoxic T lymphocyte-associated antigen (CTLA)-4. It has been reported
that CD28 triggers T cell response whereas CTLA-4 seems to suppress or
terminate T cell response. CD86 is constitutively expressed at a low lev-
els and is upregulated upon stimulation, whereas CD80 is only expressed
following stimulation (Greenwald et al., 2005).
HLA-ABC and HLA-DR: For the two groups of MHC receptors, HLA-ABC
was chosen for class I, which is expressed on virtually every cell surface,
and HLA-DR for class II, which is restricted to APC.
3.7 Apoptosis assay
An early event in apoptosis is the translocation of phosphatidylserine (PS) from
the inner to the outer side of the plasma membrane. In viable cells PS is lo-
cated exclusively on the inner layer of the cell membrane, whereas in apoptotic
cells the PS translocates to the cell surface. Annexin V is a molecule that binds
specifically to PS. Using flow cytometry, the location of PS can be detected using
FITC-labeled Annexin V (Vermes et al., 1995). In necrotic cells the cytoplas-
matic membrane is damaged, cells become permeable and allow Annexin V to
enter the cytoplasma and bind to PS on the inner side of the membrane. To dis-
criminate between early apoptotic cells with intact membrane and late necrotic
cells by flow cytometry, a DNA-staining dye like Propidium iodide (PI) was used.
In necrotic cells the dye enters through the damaged membrane and binds to
the cellular DNA. By plotting the fluorescence of Annexin V-FITC versus PI,
three cell populations can be discriminated: Annexin V-FITC−/PI− viable cells,
Annexin V-FITC+/PI− early apoptotic cells and Annexin V-FITC+/PI+ late
apoptotic or necrotic cells. Since apoptosis is a biochemically active process,
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requiring energy, the experiments were performed strictly on ice to halt cellu-
lar activity. About 2.5 · 105 cells were washed twice with ice cold PBS in 5 ml
polystyrene tubes and re-suspended in 200 µl staining solution, containing 2.5 µl
Annexin V and 2.5 µl PI in 195 µl Annexin binding buffer (table 7.1). After
20 minutes incubation, cells were analyzed within one hour on a FACSCalibur
flow cytometer. To allow for the best compensation parameters samples labeled
with each dye singly were also analyzed.
3.8 Allogenic T cell stimulation assay
The T cell stimulation capacity of APC can be assessed in a model of allo-
genic transplantation, the mixed leucocyte reaction (MLR), where APC are
co-cultured with allogenic T cells. The T cells recognize the MHC molecules as
non-self and get activated depending on the stimulatory or inhibitory molecules
presented by the APC. Proliferation is a good indicator for T cell activation
upon stimulation. To measure proliferation, 3H-methyl-thymidine (Hartmann
Analytica) was added in excess to replace the cells’ own thymidine pool. Thus
3H-methyl-thymidine is incorporated into the newly synthesized DNA of pro-
liferating cells. After cell lysis with deionized water, the DNA was collected
on fiberglass filters. The radioactivity, measured in counts per minute (cpm),
represents 3H-methyl-thymidine incorporated into the cellular DNA and thus
cell proliferation.
The different stimulator cells, MAC, MMAC or DC were examined for their
capacity to stimulate allogenic T cells in an allogenic MLR. The T cells were
separated from the MNC by counter-current elutriation (3.2) and frozen imme-
diately in freezing medium containing 10 % DMSO (Sigma) and 90 % fetal calf
serum (FCS)(PAA). For MLR, T cells were rapidly thawed, washed and resus-
pended in MLR medium (table 7.1). For MLR, 5·104 T cells were incubated at
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stimulator: responder ratios from 1:2 till 1:1250. The cells were cultured in 96-
well round bottom tissue culture plates (Falcon) in a total volume of 200µl MLR
medium (table 7.1). As negative controls, T cells and stimulator cells were also
incubated alone. After 6 days, 1 µCi 3H-methyl-thymidine (0.037 MBq specific
activity) was added to each well. Following a total incubation of 7 days, cells
were harvested onto glass fiber filters (Printed Filtermat B, Wallac Oy) using a
Vacusafe IH280 harvester (Innotech) and subsequently lysed. Scintillation fluid
(Betaplate Scint, Wallac) was added to the filters and the radioactivity was de-
termined by a liquid scintillation counter (1450 MicroBeta, Wallac). All samples
were tested in quadruplicates and values indicate means ± SD.
3.9 Phagocytosis assay
Endocytosis is a basic feature of all eucaryote cells. The most common way is
pinocytosis, where the plasma membrane builds small vesicles containing liquids
or single molecules. Phagocytosis is more restricted to phagocytic cells like
macrophages. Here the cell can engulf big particles like bacteria or virus, forming
phagosomes which later fuse with lysosomes that contain enzymes to degrade
the engulfed content. The phagocytic capacity was assessed by the cells’ ability
to ingest small fluorescently labeled latex. The phagocytized fluorescent beads
could be monitored by flow cytometry.
Therefore, the harvested cells were washed and resuspended in polypropylene
tubes (to prevent adhesion to the tubes) at 106 cells/ml with fresh medium.
The cells were incubated with 0.5 µl FITC-labeled Flouresbrite Microspheres
latex particles with 1.0 micron diameter (Polyscience) at 37◦C in an oscillating
water bath to insure continuous exposure of the cells to the beads. To control
for random sticking of the beads to the cell surface, cells treated with beads
were incubated on ice with additional 6 mM EDTA (Sigma) to totally inhibit
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phagocytic uptake. After 1h incubation was stopped by placing the cells on ice
and adding 6 mM EDTA. Following 3 washes an average of 30,000 cells was
analyzed in a FACSCalibur (Beckton-Dickinson).
3.10 Cytokine production following stimulation with LPS
One main feature of macrophage or DC activation is increased cytokine secre-
tion. To determine how the different cells react to an activation stimulus in
terms of cytokine production, they were incubated with LPS, and the super-
natant was analyzed for secreted cytokines. To this end, monocytes or cells
after 7 days in culture were harvested, washed and 2·106 cells were cultured in
2 ml fresh medium for additional 24h with or without 10 ng/ml LPS. The su-
pernatants were collected and further centrifuged for 30 minutes at 13,000 rpm
(ultra centrifuge, Beckmann) to remove cellular debris, and stored at −20◦C
in micro test tubes (Eppendorf) for later enzyme-linked immunosorbent assay
(ELISA) analyses. The following ELISAs were performed according to the man-
ufacturer’s instructions: IL-10 (Becton-Dickinson), IL-12p70 (eBioscience), and
TNF-α (eBioscience).
3.11 Statistics
Statistic analyses were performed with SPSS (SPSS). For descriptive statistics
mean and standard deviation (SD) were calculated. All data was continuous and
metric but not normally distributed, which was tested with the Kolmogorov-
Smirnov test. Therefor tests for non-parametric data were applied on further
statistic analyses. All experiments from one donor were treated as related data,
the results of different donors treated as independent data. To evaluate a differ-
ence between multiple paired data, Friedman-test and post-hoc Wilcoxon Signed
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Ranks Test were used to evaluate if a difference between a set of non-parametric
data was statistically significant. For p ≤ 0.05 the difference between two values
was considered to be statistically significant.
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4.1 Survival of monocytes under non-adherent conditions
condition mean of vital cells (%) SD p n
MAC 50.1 8.9 > 0.05 (12)
MMAC 50.5 13.4 (13)
MAC + M-CSF 40.8 9.4 > 0.05 (3)
DC 40.2 10.7 > 0.05 (8)
Table 4.1: Survival rates of different culture conditions. The viability
of MAC, MMAC, MAC + M-CSF and DC after 7 culture days was estimated
by trypan blue staining. The % vital cells refers to the percentages of the initial
seeded monocytes alive after 7 days in culture. Statistical analyses showed no
significant differences, p refers to the difference to MMAC. Mean values of n
independent experiments, SD: standard deviation.
In short, we wanted to study whether monocytes in suspension, such as in
peripheral blood can survive and eventually differentiate. We thus used a culture
system developed earlier by members of this workgroup (Arndt et al., 2007),
whereby monocytes are grown completely adhesion-free and compared these
cells with conventionally differentiated MAC. The viability of cells under all
different culture conditions was determined by trypan blue staining (3.1.4) at
the end of any culture period before further processing. The number of viable
cells was set in ratio to the number of cells at the beginning of the culture period.
Table 4.1 shows the results of all experiments on day 7. There was no signif-
icant difference between the survival rate of adherent MAC (50.1%) and non-
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adherent MMAC (50.5%). The poorer values of MAC + M-CSF (40.8%) were
statistically not significant lower than MAC’s or MMAC’s.
4.2 Detection of apoptotic cells
Condition n % vital cells % apoptotic cells % dead cells p
mean SD mean SD mean SD
Mono 3 84 16 1 1 13 14
MAC d3 4 77 15 5 7 12 3 > 0.05
MMAC d3 4 65 24 5 5 25 21
MAC d7 4 81 8 5 5 11 4 > 0.05
MMAC d7 4 75 7 6 5 16 4
DC d7 2 68 3 13 1 17 2 > 0.05
Table 4.2: Distribution of vital, apoptotic and dead cells. Monocytes
and freshly harvested MAC, MMAC and DC at different timepoints were stained
with Annexin V FITC/PI and analyzed with a flow cytometer. Results of quad-
rant analyses, the table shows mean values and SD of n independent experi-
ments. No significant differences were found between MMAC and MAC or DC.
In the Annexin V FITC/PI assay (3.7) freshly isolated monocytes showed a
viability of 84 % and showed almost no apoptotic cells. After a culture period
of 3 days, the harvested MAC showed a viability of 77 % with 5 % apoptotic
cells and 12 % dead cells, the corresponding MMAC had a viability of 65 %
with 5 % apoptotic cells and 25 % dead cells, the difference was not significant
for vital, apoptotic or dead cells. After a culture period of 7 days MAC showed
a viablity of 81% with 5 % apoptotic and 11 % dead cells, MMAC were viable
to 75% with 6 % apoptotic and 16 % dead cells. DC on day 7 were viable to 68
% with 13 % apoptotic and 17 % dead cells, also with no significant differences
(figure 4.2).
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Figure 4.1: Detection of apoptotic cells in FACS-Analysis. Monocytes
and freshly harvested MAC and MMAC at different timepoints were stained
with Annexin V FITC/PI and analyzed with a flow cytometer. The figure
shows dotplots of one representative two color analysis, results of the quadrant
analyses are represented by the numbers in the small cross.
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Figure 4.2: Morphology in light microscopy. Light microscopic images of
MAC and MAC + M-CSF adherent on teflon (a & b) and of loosened MAC,
MMAC, DC and loosened MAC + M-CSF (c, d, e & f) in suspension. Magnifi-
cation 100x, native cells without staining.
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4.3 Morphology in light microscopy
The morphology of the cells was also evaluated in parallel with the viability by
light microscopy (3.4). The MAC showed spindle shaped bodies when attached
to the Teflon membrane (figure 4.2 a). The extra M-CSF in the MAC + M-CSF
culture did not cause any morphological changes (figure 4.2 b) different from
those observed in MAC. In the DC culture, the non-adherent cells were smaller
in size and had typical dendrites (figure 4.2 e). In suspension, MMAC presented
a highly granular round body with small cell plasma protrusions (figure 4.2 d).
The loosened MAC + M-CSF looked similar to the loosened MAC (figure 4.2
c & f). All three macrophage populations, MAC, MMAC and MAC + M-CSF
attached rapidly to the usual glass microscope slides displaying a classic ’fried
egg’ form.
4.4 Phenotype characterization with monoclonal
antibodies
After establishing the similar survival rates of non-adherent MMAC and adher-
ent MAC, the question occured whether the surviving cells actually underwent
differentiation. As cell differentiation is associated with changes in surface anti-
gen expression, the phenotype of these cells was determined using fluorescently
tagged antibodies against differentiation-associated antigens which were identi-
fied with flow cytometry.
MMAC had higher values in FSC and SSC, corresponding to higher granular-
ity and cell size compared to MAC (figure 4.3 a). Figure 4.3 depicts data from
one representative experiment for MAC, MMAC and DC after 7 days. In gen-
eral, MMAC had a higher auto-fluorescence, mainly in the FITC-channel, which
made adjustment of the instrument settings necessary to bring the background
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fluorescent reading (isotype control) into a minimum. No significant differences
could be found for the adherently cultured MAC + M-CSF, which had extra
M-CSF, compared to MAC, which lacked extra M-CSF. Thus, MAC + M-CSF
are present on the bar graphs for illustration, but are not further mentioned in
the following paragraphs.
4.4.1 Antigens of macrophage differentiation: CD14, CD16, CD71,
CD84 and MAX.11
All isolated monocytes (610 ± 109 mean ± SD MFI), MAC (429 ± 172) and
MMAC (861 ± 323) expressed CD14 at a high level in comparison to the down-
regulation seen in monocyte to DC (52 ± 39) differentiation. Still, the CD14
expression on MMAC was higher than on MAC, which was already significant
after 3 days. MAC (73 ± 37) and MMAC (169 ± 98) expressed higher levels
of CD16 than did the freshly isolated monocytes (38 ± 27). But the CD16
expression on MMAC was even higher than on MAC, a difference that was even
more pronounced on day 3 (17 ± 14 vs. 197 ± 116). Expression on DC was
very weak (7 ± 8). Freshly isolated monocytes did not express CD71, but it
was detected on all differentiated cells (MAC 77 ± 51, MMAC 33 ± 9, DC 35 ±
31). Low CD84 expression was found on monocytes (27 ± 6) and DC (43 ± 25),
slightly, but not significant higher levels were seen on both MAC (366 ± 151)
and MMAC (285 ± 128), which expressed equivalent levels of CD84 already
on day 3 (263 ± 22 vs. 257 ± 26). MAX.11 was absent on freshly isolated
monocytes, but expressed by all differentiated cells. A high level was seen on
MAC (518 ± 172), compared to significantly lower amounts on MMAC (133 ±
94) and DC (186 ± 108). Already by day 3, the level of MAX.11 apparent on
MAC (429 ± 136) exceed that apparent on MMAC (76 ± 65).
For details see figures 4.4 and 4.5.
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4.4.2 Cell surface antigen of DC differentiation: CD1a
Beside the high expression of CD1a on DC (1544 ± 1397), only low levels were
observed on the other cells. Notably, CD1a expression on MMAC was not
constant: MMAC of some donors expressed low levels of CD1a while those of
others didn’t, resulting in the slightly, but not significant higher levels seen on
MMAC (22 ± 28) compared to MAC (6 ± 6).
See also figure 4.5.
4.4.3 Functional antigenes of antigen presenting cells: CD40,
DC-SIGN, CD80/CD86, HLA-ABC and HLA-DR
CD40 was not detected on monocytes. The highest level was found for DC (62
± 20), significantly lower levels for MAC (27 ± 8) and even lower amounts were
present on MMAC (15 ± 7). DC-SIGN expression was low on monocytes (28 ±
21) and MAC (11 ± 9). DC (337 ± 185) expressed the highest levels whereas
levels on MMAC (116 ± 118) were moderate, significantly distinct from that of
MAC and DC. The changes in DC-SIGN expression seemed to be a late event
in differentiation pathway, as no difference could be noticed at day 3 (MAC 62
± 27, MMAC 56 ± 5). No expression of CD80 was detected on monocytes,
MAC or MMAC, and only a very low expression was seen on DC (9 ± 13).
Compared to freshly isolated monocytes (24 ± 10), CD86 was equally more
intensely expressed on all cell types (MAC 56 ± 22, MMAC 75 ± 29, DC 83 ±
106). Freshly isolated monocytes expressed the highest levels of HLA-ABC (412
± 409) and modest levels of HLA-DR (81 ± 57). All cells down-regulated HLA-
ABC upon differentiation (MAC 193 ± 321, MMAC 200 ± 249, DC 48 ± 134).
The level of HLA-DR expression was stable on MAC (60 ± 51), but up-regulated
on MMAC (174 ± 132) and even more on DC (434 ± 294) respectively.
See also figures 4.6 and 4.7.
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Figure 4.3: Flowcytometric analysis of differentiation antigens ex-
pressed by one representative donor after 7 days in culture. (a)
FSC/SSC dot plots with gate settings; (b) overlaid histograms of MAC (filled
light grey), MMAC (unfilled black) and DC (unfilled grey). IgG1: Isotype con-
trol, GaM: second antibody goat-anti-mouse.
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Figure 4.4: Expression pattern of macrophage antigens during differ-
ent days of differentiation - bars: mean values of mean fluorescence intensity;
error bars: SD; small numbers above the bars: number of experiments; Mono:
untreated monocytes, t0; ? indicates a difference with p < 0.05.
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Figure 4.5: Expression pattern of macrophage antigens and CD1a
during different days of differentiation - bars: mean values of mean flu-
orescence intensity; error bars: SD; small numbers above the bars: number of
experiments; Mono: untreated monocytes, t0; ? indicates a difference with p <
0.05.
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Figure 4.6: Presence of surface molecules associated with APC during
different stages of differentiation - bars: mean values of mean fluorescence
intensity; error bars: SD; small numbers above the bars: number of experiments;
Mono: untreated monocytes, t0; ? indicates a difference with p < 0.05; ND: not
detected;
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Figure 4.7: Expression profile of CD86, HLA-ABC and HLA-DR dur-
ing cell differentiation along the monocytic lineage - bars: mean values
of mean fluorescence intensity; error bars: SD; small numbers above the bars:
number of experiments; Mono: untreated monocytes, t0; ? indicates a difference
with p < 0.05;
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Figure 4.8: Phagocytosis assay with fluorescent latex beads. a - his-
tograms of a representative experiment, cells after 1h incubation with latex
beads at 37◦C (filled graphs) or on ice (unfilled graphs); b - percentage of
phagocytic cells, corresponding to the marker in a; c - MFI values of the cells
under the marker; bars - mean values of n independent experiments; error bars:
SD; ? indicates a difference with p < 0.05;
The phagocytic capacity was examined using the cells’ ability to engulf fluo-
rescent latex beads. The analyzed cells had the fluorescence distribution shown
in figure 4.8 a. The first big peak can be attributed to autofluorescence of the
cell. The following distinct peaks result from the uptake of one, two and more
beads by a single cell. Because in the control samples some cells seemed to bind
at least one bead, a marker was set for more than one bead. DC (13% ± 8) did
hardly take up latex beads. The number of cells that ingested more than one
bead did not differ significantly between MAC (48% ± 17) and MMAC (61% ±
15) (see figure 4.8 b). But on average MMAC did incorporate significantly more
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beads per cells than MAC. This difference is represented by a higher MFI for
MMAC (2152 ± 2022) compared to MAC (610 ± 420) under the marker (see
figure 4.8 c).
4.6 Activation of APC with bacterial endotoxin
The stimulation and subsequent cytokine secretion of APC is an important step
for the activation of the adaptive immune system. Several macrophage activa-
tion patterns have been described, leading either to propagation or inhibition
of the inflammatory process. Here, the cells were activated with the ’classical’
macrophage stimulus LPS without prior priming.
The supernatants of the unstimulated MMAC contained more IL-10 than
MAC, more pronounced on day 3 (253 pg/ml ± 266 vs. 17 pg/ml ± 20) com-
pared to day 7 (133 pg/ml ± 220 vs. 27 pg/ml ± 35). The contents of IL-10
in DC ( 46 pg/ml ± 80) cultures were comparable to MMAC at day 7. Upon
stimulation, all cells produced significantly more IL-10. MMAC (3212 pg/ml ±
2459) on day 7 exceeding the similar values of MAC (1071 pg/ml ± 909) and
DC (1670 pg/ml ± 1913). The IL-12 secretion was low for all culture conditions
before and after stimulation, the only significant rise was seen after the stimula-
tion of monocytes (22 pg/ml ± 15 to 52 pg/ml ±29). The testing for TNF-α in
unstimulated cultures after 7 days showed a tendency to higher levels in MMAC
(703 pg/ml ± 642) and DC (1183 pg/ml ± 195) compared to monocytes (90
pg/ml ± 52) or MAC (91 pg/ml ± 46). However, these differences were not
statistically significant. Stimulation with LPS resulted in higher TNF-α values
for MMAC (4885 pg/ml ± 2448), MAC (2702 pg/ml ± 2828) and DC (3131
pg/ml ± 4368), also with no significant difference.
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Figure 4.9: Cytokine production upon stimulation with LPS. Mono-
cytes (Mono) or freshly harvested MAC, MMAC and DC after 3 and 7 culture
days were incubated with or without 10 ng/ml LPS for 24h and the supernatants
analyzed with specific ELISAs for IL-10, IL-12p70 and TNF-α. Bars - mean val-
ues of n independent experiments, error bars: SD, small numbers on the bars:
number of independent experiments, ? indicates a difference with p < 0.05.
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4.7 Allo-reactiv T cell response
The ativation of T cells by APC is critical for the function of the adaptive
immune system. The stimulatory capacity of the different APCs was tested in a
MLR (3.8). Proliferative capacity of allogenic T cells in cocultures with MMAC
(ratio 1:1 15347 cpm ± 22343 mean ± SD, ratio 1:2 8545 cpm ± 13339) was
stronger than in cocultures with MAC (ratio 1:1 2389 cpm ± 1493, ratio 1:2 2347
cpm ± 1528). However, MMAC did not induce the high proliferation activity
seen in cocultures with DC (ratio 1:1 32463 cpm ± 31481, ratio 1:2 18792 cpm
± 8996). The difference between MAC, MMAC and DC were significant for
both the 1:1 and the 1:2 ratio. Proliferation of the stimulator or responder cells
cultured alone was not seen.
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Figure 4.10: Allogenic activation of T cells by MAC, MMAC and
DC. Allogenic T cells were incubated with either macrophages, MMAC or DC
at the different stimulator responder ratios indicated. On day 6, 3H-methyl-
thymindine was added. After 24 hours the cocultures were harvested. Values
indicate means of cell-associated radioactivity +/- SD of quadruplicates. One
representative out of 6 experiments is shown.
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5.1 Survival
The in vitro differentiation of monocytes to macrophages usually implicates
an adherent culture condition, which is caused particularly by the nature of
monocytes to adhere to the commonly used culture plates. One disadvantage of
this culture method is that such differentiated cells firmly stick to their tissue
plates, demanding quite a force to harvest them for further analyses. Thus,
Andreesen et al. (Andreesen et al., 1983) cultured monocytes semi-adherent on
hydrophobic Teflon foils from where they could be harvested without damaging
the cells’ integrity. However, in the absence of human serum, these Teflon grown
monocytes required exogenous M-CSF for survival (Andreesen et al., 1990) in
contrast to monocytes cultured firmly adherent on plastic (Haskill et al., 1988).
It could later be shown that the quantity of M-CSF physiologically present in
human serum is enough to assure monocyte survival on Teflon foils (Brugger
et al., 1991). To elucidate the impact of adhesion on monocyte survival or
apoptosis, a non-adherent culture system developed by members of this group
and published by Arndt et al. (Arndt et al., 2007) was used for this study
(3.3.3). It has been showed by Mondal (unpublished data) that non-adherently
cultured monocytes undergo apoptosis even in the presence of human serum as
a result of the rapid loss of the anti-apoptotic protein Mcl-1 which could be
inhibited by addition of exogenous M-CSF.
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The similar survival rates of MMAC and MAC (4.1) underline the proposed
anti-apoptotic effect of M-CSF on monocytes and demonstrate that adhesion
is not an absolute condition for monocyte survival. The additional Annexin
V/PI staining confirmed the results of the trypan blue staining in that no early
apoptotic cells were counted as vital. Focusing on apoptosis, responsible for
the loss of about 50% of seeded cells under all conditions, it was remarkable
that only about 10% dead cells were found at the end of the culture period. It
cannot be ruled out that the remaining ones, in both, adherent and non-adherent
conditions, ingested the apoptotic cells. Human blood monocytes have been
shown to phagocytise apoptotic cells already after their third day in circulation
(Mikolajczyk et al., 2009).
5.2 Differentiation
Monocytes give rise to all different kind of tissue macrophages, DC subsets and
osteoclasts. Although specific monocyte subsets have been described to differ-
entiate preferably to DC (Randolph et al., 2002), no specific monocyte char-
acteristics have been found that lead to the various macrophage types in the
different tissues (Hume, 2006, 2008). It seems more likely that the monocytes
enter the tissues randomly, but retain a certain plasticity to react to the local
microenviroment rather than exhibiting multiple but distinct subpopulations
(Stout and Suttles, 2004). As an inflammatory process is never static, mac-
rophages could change their phenotype according to the stage of the process
(Stout et al., 2005, 2009). DCs and osteoclasts might be terminally differen-
tiated exceptions (Palucka et al., 1998). The micro-enviroment is defined by
stromal and lymphoid cells, ECM, and soluble factors. This implicates the very
important role for cell-cell and cell-substrate interactions, influencing a broad
range of cellular characteristics, as reviewed by Shi et al. (Shi and Simon, 2006).
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On the other hand, monocytes and differentiated macrophages are also found
in body fluids like blood, peritoneal, pleural and synovial fluid. After having
establishing that monocytes can survive in suspension culture, it remained to
be proven that these cells had also differentiated. In fact, the surviving cells in
the suspension culture did not remain static, rather they underwent tremendous
morphological changes.
By light microscopy, MMAC in suspension did not show pseudopodia as did
the adherent MAC and MAC + M-CSF. Compared to MAC and MAC + M-CSF
in suspension, the only distinguishing feature of MMAC were little cytoplasmic
protrusions. As this characterized only MMAC and not MAC + M-CSF, this
could be caused by the non-adherent culture condition. Further demonstrated
MMAC a strong capacity to attach to the usual glass slides, as did MAC in
suspension.
By flow cytometry, MMAC were observed as large, highly granular cells with
high values in the FSC and SSC, according to the light microscopic observations.
The two different populations shown in the MMAC FSC/SSC dot plot did not
reveal any distinguishing features in further analyses. Moreover, all analyzed
cells were fixed in paraformaldehyde. In the vital staining with Annexin V/PI,
where cells were processed immediately without fixation, this feature could not
be reproduced and MMAC showed an unique population in the FSC/SSC dot
plot. Thus this was most likely an artifact due to the fixation procedure. MMAC
also were more auto-fluorescent compared to MAC. Likewise, Njoroge (Njoroge
et al., 2001) describes a non-adherent cell population in an adherent monocyte
culture, resembling MMAC with high auto-fluorescence and an ability for re-
attachment.
Flow cytometric analysis with monoclonal antobodies demonstrated that MMAC
did not only survive, but clearly had differentiated into a macrophage-like phe-
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notype. Notably, the additional M-CSF in the MAC + M-CSF culture did
not cause any significant difference to MAC. MMAC upregulated CD14, CD16,
CD71, CD84 and MAX.11 compared to monocytes, as did MAC. All these
markers are known to be related to monocyte to macrophage differentiation
(Andreesen et al., 1990).
However, MMAC showed a remarkable elevation of CD16 expression as an
early event after 3 days, at a time-point when adherent MAC showed still low
CD16 expression. A similar human CD14+CD16+ monocyte sub-population
was described in several diseases, such as AIDS (Cassol et al., 2006), rheumatoid
arthritis (Kawanaka et al., 2002b) and chronic renal failure (Kawanaka et al.,
2002a). This CD16+ subset is also expanded after treatment with M-CSF in
both humans (Saleh et al., 1995) and primates (Munn et al., 1996). These cells
have been described as a more mature type of blood monocytes, differentiated
in the blood under the influence of elevated levels of serum M-CSF and other
inflammatory cytokines (Kawanaka et al., 2002b; Saionji and Ohsaka, 2001).
Since the culture conditions of MMAC resembled in part the situation in the
blood, these in vitro results suggest that monocytes in a non-adherent condition
can differentiate into a macrophage-like effector cell.
Even though adhesion is not an absolute condition to monocyte differentia-
tion, it undoubtedly has an influence on the cells’ characteristics. Adherence,
for example to collagen molecules, induces CD14 down-regulation (Jacob et al.,
2002). As MMAC lack adhesion, these findings stand in agreement with the
results that CD14 expression in MMAC remained at a high level in contrast to
the down-regulation in adherent MAC.
Taken into consideration that blood monocytes can give rise also to DCs,
MMAC were compared not only to MAC but also to DC. Considering the light
microscopic phenotype and the markers of macrophage differentiation discussed
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above, MMAC showed clearly a macrophage-like phenotype. In addition to that,
no expression of the DC-marker CD1a was detected in any culture condition
except DC.
To account for the antigen presenting function of the evaluated cells, the
expression pattern of antigen presenting and costimulatory molecules that cor-
relate with their function as APCs were determined. Upon differentiation from
the monocyte, the expression of MHC class I molecules diminished equally in
MMAC and MAC. In contrast, the level of MHC class II molecules was stable
in MAC, but increased in MMAC and to an even higher degree in DC. No sig-
nificant difference was found for the costimulatory molecules of the B7 family.
CD80 was very weakly expressed on DC and not detected on any of the other
cells. CD86 was equally upregulated on all cells in the differentiation process
from monocytes. However, significant difference was found in the expression
of the T cell adhesion molecules CD40 and DC-SIGN. Both molecules were
present mostly on DC. But whereas CD40 expression was lower in MMAC than
on MAC, the opposite was found for DC-SIGN, where the expression was higher
on MMAC than on MAC. The characterization of DC-SIGN as a DC marker has
been challenged by the discovery that in patients with leprosy, the macrophages
express DC-SIGN and CD16, whereas the DC, characterized by CD1 lack fDC-
SIGN (Krutzik et al., 2005). More recently, CD14+ DC-SIGN + macrophages
in the lamina propria were described as potent antigen presentig cells and are
supposed to play an important role in maintaining the immunological balance
in the gut (Kamada et al., 2009).
Conclusively, the phenotype of MMAC is clearly macrophage-like, with some
APC-related markers more accentuated. In part, MMAC resemble the pheno-
type of peritoneal macrophages, which was reported for other M-CSF differen-
tiated monocytes before (Xu et al., 2007; Akagawa et al., 2006). In patients un-
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dergoing peritoneal dialysis, the monocytes invading the peritoneum expressed
high CD14, CD16, CD71 and HLA-DR (Andreesen et al., 1990; Brauner et al.,
1998). The M-CSF levels in the peritoneal fluid are higher even in healthy in-
dividuals (Weinberg et al., 1991), but rise in accordance to high M-CSF blood
levels, for example in patients undergoing dialysis (Saionji and Ohsaka, 2001).
5.3 Phagocytosis
Endocytosis is performed by all eucaryotic cells in form of uptake of liquids and
single molecules into small plasma membrane enclosed vesicles, which is referred
to as pinocytosis. The engulfment of big particles like bacteria is restricted to
professional phagocytes. All antigen-presenting cells are also phagocytes but
the various subtypes differ considerably in their phagocytic capacity. DCs are
very good antigen presenting cells but poor phagocytes, macrophages instead
are very good phagocytes but weak antigen presenting cells. Macrophages are
distinguished by their ability to ingest large particles. They even can merge
together and form multinuclear giant cells in order to digest a larger foreign
body.
Functionally, MMAC appear to be a more efficient MAC. Its phagocytic ca-
pacity is more robust than that of an adherently-generated MAC. Again this
could be due to the extra M-CSF in the culture media, as M-CSF is known to
enhance phagocytosis (Akagawa, 2002; Nemunaitis, 1998). Moreover, the strong
expression of CD14, CD16, and DC-SIGN on MMAC, which all are involved in
antigen uptake, could also account for this caracteristic. There was no uptake
of beads in DC as expected.
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Another keystone to the activation of the immune system is cell-cell interac-
tion via cytokines. Upon stimulation with LPS, all cells secreted high amounts
of IL-10 and TNF-α, confirming previous results of this group for MAC and
DC (Ammon et al., 2000). MMAC however produced more IL-10 and TNF-α
compared to MAC upon stimulation. In contrast to monocytes, which secreted
IL-12 following stimulation, no increase of this cytokine was found in MAC and
MMAC.
MMAC constitutively produced IL-10. Accordingly, Smith et al. (Smith
et al., 1998) found the same cytokine secretion pattern with high IL-10 and low
IL-12 secretion for MAC, DC and MAC + M-CSF. They found that constitutive
IL-10 secretion of M-CSF-induced macrophages did not account for low IL-12
levels, as it occurred also in the presence of inhibitory anti-IL-10-antibodies.
Constitutive IL-10 secretion was also found for M-CSF induced macrophages
that also were highly active in phagocytosis (Xu et al., 2006), although in this
report, these macrophages did not produce TNF-α as did MMAC. Conclusively
the CD14+ CD16+ monocytes were identified as main producers of IL-10 in the
blood (Skrzeczyn´ska-Moncznik et al., 2008).
5.5 T cell stimulatory capacity
Cocultures of allogenic T cells with MMAC caused a T cell proliferation much
more pronounced than with MAC, but not as potent as with DC. This is in
accordance with higher expression of MHC class II molecules and DC-SIGN on
MMAC. DC-SIGN is important for the early T cell - APC interaction and results
in profound T cell stimulation (Geijtenbeek et al., 2002; Gijzen et al., 2007).
DC-SIGN can be induced by cyclic nucleotides, which inhibit DC generation
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and favor a cell type expressing high MHC class II and CD86 molecules, and
a high proliferative T cell response in MLR (Giordano et al., 2003). The weak
proliferation of T cells in coculture with MAC is in line with the inhibitory
proprieties of non-activated MAC, which have recently been stated (Hoves et al.,
2006). The M-CSF in MMAC cultures could be responsible for a more activated
cell type, as M-CSF seems to favor the alternative activation pathway (Martinez
et al., 2006). Also IL-10 could have an influence on the T cell activation, as it
inhibits TH1 response, favoring the generation of TH2 cells (Conti et al., 2003).
Interestingly, MMAC showed higher phagocytosis rates and higher stimula-
tory capacity toward T cells, two items that generally are divergent. Monocytes
loose their phagocytic capacity and gain better antigen presenting upon differ-
entiation towards DC.
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The results of this study establish that monocyte adhesion, which undoubtedly
is responsible for many substantial changes in the monocyte, is not essential
for monocyte survival and differentiation to a macrophage-like cell. As mono-
cytes and their differentiated forms are found, not only in the extra cellular
matrix, but also in suspension in the blood and the peritoneal fluid, this can
help to understand their function under these circumstances. Many details have
been revealed for the different monocyte subsets. This study gives now further
substance for the hypothesis that the CD16+ monocytes are a more mature
subset, differentiated in the blood under the influence of M-CSF. Moreover,
MMAC have as a unique feature the upregulation of both, phagocytosis and
T cell stimulatory capacity, two functions that usually are not up-regulated in
parallel. Whether this new macrophage type has its own place in the MPS, or
it stands for another possible phenotype of a chameleon like cell type, known as
the macrophage, remains to be elucidated.
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7 Zusammenfassung
Monozyten und die aus ihnen hervorgehenden Makrophagen und dendritischen
Zellen (DC) haben im Immunsystem des Menschen eine besondere Rolle als
Bindeglied zwischen dem angeborenen und dem adaptiven Immunsystem. In
vielen Experimenten zur Differenzierung von Makrophagen aus Monozyten er-
wies sich der Wachstumsfaktor M-CSF als u¨berlebensnotwendig. Dabei wurden
jedoch die Monozyten stets adha¨rent kultiviert, sodass der Einfluss von M-CSF
auf die Differenzierung nie unabha¨ngig von den Auswirkungen der Adha¨sion
betrachtet werden konnte. M-CSF kommt auch in nennenswerten Mengen im
Blut gesunder Individuen vor und kann bei bestimmten Krankheiten in deutlich
ho¨heren Konzentrationen nachgewiesen werden. Da Monozyten auf ihrem Weg
vom Knochenmark zum Gewebe einige Zeit im Blut zirkulieren und sich dort
unter dem Einfluss von M-CSF vera¨ndern ko¨nnten, wurde versucht diese Um-
gebung in vitro nachzuformen. Dafu¨r wurden humane Blutmonozyten in einer
Suspension zur Vermeidung von Zell-Zell oder Zell-Substrat-Kontakten und un-
ter Zugabe von rekombinantem M-CSF in einer rotierenden Flasche kultiviert.
Diese durch M-CSF induzierten Makrophagen (MMAC) exprimierten signi-
fikant ho¨here Werte der Oberfla¨chenantigene CD14, CD16, HLA-DR und DC-
SIGN im Vergleich zu adha¨rent generierten Makrophagen (MAC). Im Vergleich
zu DC zeigten sie niedrigere Werte der Marker CD1a und DC-SIGN, jedoch
ho¨here Werte der Marker CD84 und HLA-ABC. Nach Stimulation mit Lipopo-
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lysaccharid (LPS) produzierten MMAC, analog zu den DC, Interleukin (IL-)10
und Tumornekrosefaktor (TNF-)alpha. Im Vergleich zu MAC zeigten MMAC
eine deutlich erho¨hte Phagozytoserate und T Zell stimulierende Eigenschaften.
Zusammenfassend zeigten sich MMAC als Makrophagen-a¨hnliche Zellen mit
ausgepra¨gten Effektoreigenschaften, die jedoch nicht an die der DC heranreich-
ten.
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7.1 Solutions and media
Annexin V- 10 ml 1M HEPES (Sigma)
binding buffer: 8.12 g NaCl (Merck)
0.28 g CaCl2 (Merck)
ad 1000 ml ultra pure water
DC medium: 500 ml RPMI 1640 (Biochrom)
5 ml L-Glutamine (Biochrom)
5 ml Sodium pyruvate (100 mM, Gibco)
5 ml Non-essential amino acids (100 x, Gibco)
2 ml Vitamins (100 x, Gibco)
2.5 ml Penicillin-Streptomycin (104 U/ml, Gibco)
0,5 ml 2-Mercaptoethanol (50 mM, Gibco)
add 10 % fetal calf serum (FCS, PAA) right before use
FACS fixative: 500 ml PBS (PAN)
50 ml Paraformaldehyde (10 % w/v in PBS, Sigma)
FACS washing buffer: 500 ml PBS (PAA)
5 ml Immunoglobulin (60 mg/ml, Sandoz Pharma)
5 ml Sodium acide ( 10 % w/v in PBS, Sigma)
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Macrophage medium: 500 ml RPMI 1640 (Biochrom)
5 ml L-Glutamine (Biochrom)
2.5 ml Penicillin-Streptomycin (104 U/ml, Gibco)
add 2 % pooled AB-group serum (Cambrex) right before use
MLR medium: 500 ml RPMI 1640 (Biochrom)
5 ml L-Glutamine (Biochrom)
5 ml Sodium pyruvate (100 mM, PAN)
5 ml Non-essential amino acids (100 x, PAN)
2 ml Vitamins (100 x, PAN)
2.5 ml Penicillin-Streptomycin (104 U/ml, Gibco)
0,5 ml 2-Mercaptoethanol (50 mM, Gibco)
add 10 % pooled male human AB group serum (PAN) right before use
Trypan blue solution: 0.4 % (w/v) Trypan blue (Sigma)
in 0.9 % (w/v) NaCl (Merck) in ultra pure water
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7.2 List of all companies
7.2 List of all companies
BD Biosciences San Jose, CA, USA
BD Pharmingen San Diego, CA, USA
Beckman Coulter Fullerton, CA, USA
Beckmann Munich, Germany
Becton-Dickinson San Jose, CA, USA
Biochrom Berlin, Germany
Cambrex East Rutherford, NJ, USA
Cetus Corp. Emeryville, CA, USA
Costar Cambridge, UK
Diaclone Besanc¸on, France
eBioscience San Diego, CA, USA
Eppendorf Hamburg, Germany
Essex Munich, Germany
BD Falcon Heidelberg, Germany
Fujifilm Du¨sseldorf, Germany
Gibco Karlsruhe, Germany
Greiner Bio-one Frickenhausen, Germany
Hareus Hanau, Germany
Hartmann Analytica Munich, Germany
Immunotech Marseille, France
Immunotools Friesoythe, Germany
Innotech Dottikon, Switzerland
Jackson ImmunoResearch Suffolk, UK
Merck Darmstadt, Germany
PAA Linz, Austria
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PAN Aidenbach, Germany
PeliCluster Amsterdam, Netherlands
Pharmacia Freiburg, Germany
Polyscience Warrington, PA,USA
Sandoz Pharma AG Basel, Swizzerland
Sigma Deisenhof, Germany
SPSS Chicago, USA
Wallac Milton Keynes, UK
Wallac Oy Turku, Finnland
Zeiss Jena, Germany
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